Select Page

Functional RNAi and CRISPR Screening and Drug Target & Biomarker Discovery

Cellecta Inc., a functional genomics solutions provider, focuses primarily on developing and implementing flexible and scalable broad-based screening and analysis approaches for drug target and biomarker discovery. Our high-throughput functional genetic screening portfolio includes:

  • shRNA and CRISPR screening services
  • custom and off-the-shelf pooled libraries
  • knockout and knockdown cell lines

that facilitate genome-wide functional screening and the identification and validation of genes involved in critical biological and disease pathways.

With Driver-Map™ Targeted Gene Expression Profiling Service, Cellecta offers a quantitative, multiplexed approach that allows simultaneous profiling of all human protein-coding genes in one reaction, thereby providing a reliable, accurate transcriptome profile with ultra-high sensitivity.

Learn more about Cellecta >

Upcoming Events

2017 RNA-Seq Summit, Hilton San Francisco Airport Bayfront, Burlingame, CA, April 25-27, 2017
Presentation – April 26, 2017, 9:30 a.m., Poster Session, 3:30 p.m., Exhibition.

Biomarkers & Immuno-Oncology World Congress 2017, Philadelphia Marriott Downtown, Philadelphia, PA, May 2-4, 2017
Presentation – May 3, 2017, 4:40 p.m., Poster Session, Booth 8.

16th Annual World Preclinical Congress (WPC), The Westin Copley Place, Boston, MA, June 12-16, 2017
Presentation – June 13, 2017, 11:50 a.m., Poster Session, Booth 313.